Biochips - A Global Update of Market Trends & Opportunities

Jan 29, 2010, 07:21 ET from Reportlinker

NEW YORK, Jan. 29 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Biochips - A Global Update of Market Trends & Opportunities

http://www.reportlinker.com/p0164201/Biochips---A-Global-Update-of-Market-Trends--Opportunities.html

Significant dimensions of the vast parallel studies afforded by biochips have created a holistic means of viewing biological systems. In addition to the combination of various sciences, space, time and expense are all key factors in the future development of biochips. Modern day chips can contain a human genome comprising of 30,000 to 100,000 genes.

The biochip industry is in the early stages of growth and hence, not only promises potential but also is susceptible to vagaries of market forces. Competition, patent disputes, knowledge constraints (in terms of skilled employees, technical know-how) and financial strength might be a few impediments for firms engaged in this industry. A promising market arises from three factors – an aging population, third party reimbursement and a growing number of individuals suffering from common chronic diseases. Biochips would certainly evolve in terms of physical, technical characteristics, and with focus on miniaturization of assays, they would turn smaller and more powerful with each generation. The industry is characterized by both intense rivalry and equally well-developed web of alliances.

These and other market data and trends are presented in "Biochips: A Global Update of Market Trends & Opportunities" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

BIOCHIPS BMR-1001

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. INDUSTRY OVERVIEW 4

Promising Biochips Promote Biological Research 4

Market Scenario across Products and Regions 4

DNA Chips Lead the Application Front 5

Probable Industry Directions 5

Biochip Technology Boosts Personalised Medicine 6

Biochip Technology Spreads beyond Pharma Industry 7

Protein Chips to Shape the Future 7

Proteomics "Chip" into Biochip Technology 8

Towards Increasing Minaturization 8

European Advancements Set Diagnostic Procedures 8

Competitive Scenario 8

Major Participants 8

Roche and Affymetrix Taste Success in the Diagnostics Market 10

Growing Partnerships between Pharma and Biotech Companies 10

Tech Giants Join the Biochip Fray 11

3. PRODUCT FACTS 12

A. DNA Chips 12

B. Protein Chips 13

C. Lab Chips 13

4. APPLICATIONS OF BIOCHIPS 13

Biochip Uses 14

Biochips and Pharmaceutical Investigation 14

Biochips and Medical Diagnostics 15

Advantages of Biosensor Chip Technology 15

Biochips and Forensics 16

Biochips and Transplantation Screening 16

Biochips and Identity Testing 16

Biochips and Water and Environmental Testing 16

Food Industry 16

5. TRENDS 17

Industry Characteristics 17

New Products and Players to Drive Market 17

Key Forces Boosting the Industry 17

Industry Structure 17

Industry Challenges 18

Price Dearness Pauses Biochips Growth 18

Current Approaches to Biochips 19

The Business of Biochips 19

Technological Trends 20

Sensitivity 20

Microfabrication 20

Density 20

Integrated Chips 21

Patent Trends 21

Patent Applications 21

6. NEXT GENERATION TECHNOLOGY 22

Microfluidics Using CD-ROM Technology 22

7. CORPORATE DEVELOPMENTS 23

Affymetrix Acquires USB 23

Illumina Announces Partnership with Genpathway for ChIP

Sequencing Services 23

Affymetrix and Avesthagen Enter into an Agreement 24

Roche NimbleGen and Affymetrix Announce Expansion of License

Agreement 24

GATC Biotech Establishes New Subsidiary 25

Affymetrix Introduces Complete Cytogenetic Solution 25

Sigma Launches ChIP Kit 25

US and Czech Scientists to Develop Biochips for Detecting Cancer 26

Roche Takes Over NimbleGen 26

GenTel BioSciences Acquires Protein Chip Platform Assets of GSK 27

Advanced Liquid Logic Acquires Nanolytics 27

Applied Microarrays Acquires Select GE Healthcare's Assets 27

Affymetrix and Partners Healthcare Extend Collaboration 28

Agencourt, NuGEN and Affymetrix Clinical Services Collaborate 29

Affymetrix Inks Licensing Agreement with Empire Genomics 29

Caliper Enters into a Licensing Agreement with Monogram

Biosciences 30

Affymetrix and IPSOGEN Sign Agreement 30

bioMerieux and NuGEN Enter into Supply and Cross-License

Agreement 31

VWR and CapitalBio Enter into a Distribution Agreement 31

UCL Subsidiary and Roche Diagnostics Ink Licensing Deal 32

Affymetrix Establishes the European Cytogenetic Research

Initiative. 32

Roche Introduces Gene Expression Services and Arrays 32

Affymetrix Unveils Affymetrix GeneChip Command Console Software 33

Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays 33

Affymetrix Unveils Genome-Wide Human SNP Array 6.0 34

Caliper Life Sciences Launches High Throughput RNA Assay 35

Applied Biosystems Unveils DNA Tools 35

febit Launches Geniom RT Analyzer 35

Austrian Research Center Develops New Biochip Surface 36

Researchers Develop Biochips to Eliminate Animal Testing 36

8. MAJOR PLAYERS 37

Affymetrix (US) 37

Applied Biosystems Group (US) 37

Biomerieux (France) 37

Bio-Rad Laboratories, Inc. (US) 37

Caliper Life Sciences, Inc. (US) 37

Cepheid Inc. (US) 38

GE Healthcare Ltd (UK) 38

Takara Bio, Inc. (Japan) 38

Zyomyx (US) 38

9. MARKET ANALYTICS 39

10. THE UNITED STATES 43

Biochips Market Overview 43

Time Saving Biochips - All Set to Grow 43

Multiple Applications of Biochips Drive Sales 43

Biochip Market Faces Challenges 43

11. CANADA 45

12. JAPAN 46

DNA Chip Based on Printing Technology 46

DNA Chips to Reveal Links Among Genes 47

A Leading Japanese Biochip Player - Takara Shuzo 47

ICAN™ Technology for Large-Scale Production of DNA Fragments 48

13. EUROPE 50

a. France 52

b. Germany 53

c. The United Kingdom 55

d. Rest of Europe 56

14. REST OF WORLD 57

China 58

Basic Environment and Commercial Development 58

Biochip Research 58

Status of Biochip Industry in China 59

Taiwan 59

Taiwan Pursues Promise of Biochip Sector 59

International Advantage Sought 60

EXHIBITS

Table 1: Market Shares of Biochips Patent Applications in the

World - 2003

Table 2: Global Biochips Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 3: Percentage Breakdown of Global Biochips Market by

Region for the Years 2008 & 2012

Table 4: Global DNA Chips Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 5: Percentage Breakdown of Global DNA Chips Market by

Region for the Years 2008 & 2012

Table 6: Global Protein Chips Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 7: Percentage Breakdown of Global Protein Chips Market

by Region for the Years 2008 & 2012

Table 8: Global Lab Chips Market by Region for the Period

2007-2015 (Sales in US$ Million)

Table 9: Percentage Breakdown of Global Lab Chips Market by

Region for the Years 2008 & 2012

Table 10: Biochips Market by Segment in the US: 2007-2015

(Sales in US$ Million)

Table 11: Percentage Breakdown of Biochips Market by Segment

in the US for the Years 2008 & 2012

Table 12: Biochips Market by Segment in Canada: 2007-2015

(Sales in US$ Million)

Table 13: Percentage Breakdown of Biochips Market by Segment

in Canada for the Years 2008 & 2012

Table 14: Biochips Market by Segment in Japan: 2007-2015

(Sales in US$ Million)

Table 15: Percentage Breakdown of Biochips Market by Segment

in Japan for the Years 2008 & 2012

Table 16: Biochips Market by Region in Europe: 2007-2015

(Sales in US$ Million)

Table 17: Percentage Breakdown of Biochips Market by Region in

Europe for the Years 2008 & 2012

Table 18: Biochips Market by Segment in Europe: 2007-2015

(Sales in US$ Million)

Table 19: Percentage Breakdown of Biochips Market by Segment

in Europe for the Years 2008 & 2012

Table 20: Biochips Market by Segment in France: 2007-2015

(Sales in US$ Million)

Table 21: Percentage Breakdown of Biochips Market by Segment

in France for the Years 2008 & 2012

Table 22: Biochips Market by Segment in Germany: 2007-2015

(Sales in US$ Million)

Table 23: Percentage Breakdown of Biochips Market by Segment

in Germany for the Years 2008 & 2012

Table 24: Biochips Market by Segment in the UK: 2007-2015

(Sales in US$ Million)

Table 25: Percentage Breakdown of Biochips Market by Segment

in the UK for the Years 2008 & 2012

Table 26: Biochips Market by Segment in Rest of Europe:

2007-2015 (Sales in US$ Million)

Table 27: Percentage Breakdown of Biochips Market by Segment

in Rest of Europe for the Years 2008 & 2012

Table 28: Biochips Market by Segment in Rest of World:

2007-2015 (Sales in US$ Million)

Table 29: Percentage Breakdown of Biochips Market by Segment

in Rest of World for the Years 2008 & 2012

COMPANIES PROFILED

To order this report:

Biotechnology Industry: Biochips - A Global Update of Market Trends & Opportunities

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

    
    
    Contact:
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)-652-2626
    Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com